Larin 1.5/30 Kit
Product Images NDC 16714-407

9 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Larin 1.5/30 (NDC 16714-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

1 (Image 01)
Chemical structure diagrams of the active ingredients Norethindrone Acetate and Ethinyl Estradiol, as shown in the product Larin 1.5/30.*
FDA Label Image

Table1 (Table1)

Table1 (Table1)
A data table showing the lowest expected and typical failure rates during the first year of continuous use of various contraceptive methods. It lists different methods such as oral contraceptives, diaphragms, spermicides, vaginal sponge, implants, injections, IUDs, condoms, cervical cap, abstinence, withdrawal, and sterilization with corresponding failure rates expressed as percentages of women experiencing unintended pregnancy.*
FDA Label Image

Table2 (Table2)

Table2 (Table2)
A bar chart labeled 'Table II' showing circulatory disease mortality rates per 100,000 woman years by age group, smoking status, and oral contraceptive use. The chart compares mortality rates for four groups: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers) across age groups 15-24, 25-34, 35-44, and 45 and above.*
FDA Label Image

Table3 (Table3)

Table3 (Table3)
A data table titled Table III showing the annual number of birth-related or method-related deaths associated with control of fertility per 100,000 nonsterile women by fertility control method according to age groups 15-19, 20-24, 25-29, 30-34, 35-39, and 40-44. It lists methods such as no control methods, oral contraceptives for smokers and non-smokers, IUD, condom, diaphragm/spermicide, and periodic abstinence, with corresponding death rates. Birth-related and method-related deaths are distinguished.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A forest plot chart depicting effect estimates with confidence intervals from various studies on contraceptive use. The studies include the NICHD Womens Care Study, French E3N cohort, Shanghai Womens Health Study, Nursess Health Study II, Oxford Family Planning Study, and the Danish Sex Hormone Register Study. The x-axis shows effect estimates ranging approximately from -1.5 to 2.0, with points and lines representing odds ratios, relative risks, and hazard ratios for each study.*
FDA Label Image

Annual Number (Annual Number)

Annual Number (Annual Number)
A data table presenting the annual number of birth-related or method-related deaths associated with control of fertility per 100,000 nonsterile women, segmented by fertility control method and age groups from 15 to 44 years. Methods include no fertility control, oral contraceptives (non-smoker and smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with notes clarifying distinctions between birth-related and method-related deaths.*
FDA Label Image

Figure 2 (Figu2)

Figure 2 (Figu2)
Instructional diagram for using the Larin 1.5/30 oral contraceptive pill kit by Northstar Rx LLC. It illustrates how to start the pack for Sunday starters and Day-1 starters, showing placement of a day label sticker and directions to take pills from left to right each week. The diagram includes example placement of pills in three weeks labeled as yellow (active) and emphasizes starting on the correct day based on the user's period.*
FDA Label Image
FDA Label Image

Carton (Carton)

Carton (Carton)
Carton packaging label for Larin 1.5/30 (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP) kit by Northstar Rx LLC. The label indicates three blister cards, each with 21 tablets. It includes product name, ingredients, dosage form as tablets, NDC 16714-407-03, pharmacy and manufacturer information, barcodes, and usage warnings. The design features pink text and a pink flower graphic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.